ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666586 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666586; 2) Community: the network communities that were significantly associated with the response to NSC 666586; 3) Molecule: the relationships between components within communities and NSC 666586; 4) MDR: the compounds that were significantly associated with the NSC 666586.

NSC Compound Enrichment Correlation
NSC 671167 Null 0.00313644776247642 0.41636337
NSC 674913 Null 0.00313644776247642 0.44539398
NSC 683782 Null 0.00313644776247642 0.54568596
NSC 703467 Null 0.00313644776247642 0.49754219
NSC 726262 1,1'-{[(bispropane-1,N-diyl)piperzine]dioxy}bis[(11aS)-7-met hoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepi n-5-one 0.00313644776247642 0.51414755
NSC 172614 9H-Purin-2-amine, 9-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.00356954838698626 0.20186559
NSC 19441 FDA 0283 0.00356954838698626 0.13275585
NSC 672054 Null 0.00356954838698631 0.54537829
NSC 682436 Naphth[2,3-d]oxazol-9(4H)-one, 4-[(2-aminocyclohexyl) imino]-2-methyl-, acetate 0.0035949310449002 0.35839359
NSC 686560 [Di-17.alpha./.beta.-(2-ethoxy-3-hydroxyestra-1,3,5(10)-triene)-]sulphite 0.0035949310449002 0.4345889
Total:95  Current:20    [First] [Prev] [Next] [Last]